Sandell Asset Management Raised Its Stake in Pacira Pharmaceuticals (Call) (PCRX) as Share Value Rose; The Mosaic Co (MOS) Shareholder American National Insurance Company Has Increased Stake by $945,000

January 14, 2018 - By Ruchi Gupta

American National Insurance Company increased its stake in The Mosaic Co (MOS) by 225.85% based on its latest 2017Q3 regulatory filing with the SEC. American National Insurance Company bought 45,000 shares as the company’s stock declined 29.59% while stock markets rallied. The institutional investor held 64,925 shares of the agricultural chemicals company at the end of 2017Q3, valued at $1.40M, up from 19,925 at the end of the previous reported quarter. American National Insurance Company who had been investing in The Mosaic Co for a number of months, seems to be bullish on the $9.56B market cap company. The stock increased 0.55% or $0.15 during the last trading session, reaching $27.22. About 3.26M shares traded. The Mosaic Company (NYSE:MOS) has declined 7.87% since January 14, 2017 and is downtrending. It has underperformed by 24.57% the S&P500.

Tom Sandell increased its stake in Pacira Pharmaceuticals Inc (Call) (PCRX) by 278.15% based on its latest 2017Q3 regulatory filing with the SEC. Sandell Asset Management Corp bought 132,400 shares as the company’s stock rose 10.53% with the market. The hedge fund run by Tom Sandell held 180,000 shares of the health care company at the end of 2017Q3, valued at $6.76M, up from 47,600 at the end of the previous reported quarter. Sandell Asset Management Corp who had been investing in Pacira Pharmaceuticals Inc (Call) for a number of months, seems to be bullish on the $1.68B market cap company. The stock decreased 1.72% or $0.72 during the last trading session, reaching $41.5. About 1.03 million shares traded or 26.65% up from the average. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since January 14, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Among 21 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Pacira Pharmaceuticals had 80 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by H.C. Wainwright on Tuesday, July 25 with “Buy”. The firm has “Buy” rating given on Tuesday, July 25 by Mizuho. The firm has “Neutral” rating by Mizuho given on Wednesday, November 29. H.C. Wainwright maintained the shares of PCRX in report on Thursday, January 4 with “Buy” rating. The firm earned “Hold” rating on Friday, July 1 by Brean Capital. Mizuho maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) rating on Wednesday, December 21. Mizuho has “Buy” rating and $41 target. The firm has “Buy” rating by RBC Capital Markets given on Sunday, July 30. As per Monday, October 2, the company rating was maintained by Canaccord Genuity. The firm earned “Hold” rating on Friday, October 7 by Brean Capital. On Friday, July 14 the stock rating was maintained by Jefferies with “Buy”.

Investors sentiment decreased to 1.39 in Q3 2017. Its down 0.23, from 1.62 in 2017Q2. It dropped, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Natl Bank Of Montreal Can invested in 37,180 shares. Gru One Trading LP holds 10,423 shares. Nationwide Fund holds 0.01% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) or 100,534 shares. 96,504 are owned by Parametric Limited Liability Company. Northern Trust holds 498,638 shares. New York-based Pointstate Cap Limited Partnership has invested 0.36% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Piermont Capital Management Incorporated has 6,860 shares. 200 are owned by D Scott Neal. Invesco Ltd reported 0.01% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Moreover, Vantage Investment Advsrs Lc has 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Pictet Asset Management Limited reported 51,366 shares. Point72 Asset Management Limited Partnership owns 0.18% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 1.08 million shares. Waddell Reed stated it has 0.07% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Schroder Investment Group owns 947,405 shares. Fifth Third Natl Bank stated it has 1,766 shares or 0% of all its holdings.

Since August 15, 2017, it had 0 insider purchases, and 4 sales for $1.23 million activity. Another trade for 1,044 shares valued at $37,741 was sold by HASTINGS PAUL J. 3,461 shares valued at $127,192 were sold by Williams Kristen Marie on Tuesday, August 15. STACK DAVID M sold 28,885 shares worth $1.05 million.

American National Insurance Company, which manages about $1.90 billion US Long portfolio, decreased its stake in Wal (NYSE:WMT) by 7,509 shares to 148,120 shares, valued at $11.57 million in 2017Q3, according to the filing. It also reduced its holding in Honeywell International Inc. (NYSE:HON) by 3,000 shares in the quarter, leaving it with 114,190 shares, and cut its stake in Bank Of New York Mellon Corp. (NYSE:BK).

Among 22 analysts covering The Mosaic Company (NYSE:MOS), 5 have Buy rating, 2 Sell and 15 Hold. Therefore 23% are positive. The Mosaic Company had 81 analyst reports since July 22, 2015 according to SRatingsIntel. On Wednesday, August 9 the stock rating was maintained by Cowen & Co with “Hold”. The stock has “Market Perform” rating by Cowen & Co on Tuesday, January 24. HSBC downgraded it to “Hold” rating and $26.50 target in Monday, April 11 report. The stock has “Neutral” rating by Citigroup on Thursday, November 2. The rating was downgraded by IBC on Monday, April 4 to “Underperformer”. The firm has “Underweight” rating by Barclays Capital given on Tuesday, April 19. The firm has “Outperform” rating by RBC Capital Markets given on Friday, February 5. Stifel Nicolaus maintained The Mosaic Company (NYSE:MOS) on Thursday, July 13 with “Hold” rating. On Thursday, September 7 the stock rating was maintained by Stifel Nicolaus with “Hold”. On Thursday, August 4 the stock rating was maintained by Citigroup with “Neutral”.

Investors sentiment increased to 1.24 in 2017 Q3. Its up 0.34, from 0.9 in 2017Q2. It is positive, as 36 investors sold MOS shares while 129 reduced holdings. 47 funds opened positions while 157 raised stakes. 258.00 million shares or 0.68% less from 259.77 million shares in 2017Q2 were reported. S&T National Bank Pa holds 1.03% of its portfolio in The Mosaic Company (NYSE:MOS) for 267,326 shares. Td Asset Mgmt reported 0% stake. Moreover, State Of Wisconsin Invest Board has 0.03% invested in The Mosaic Company (NYSE:MOS). Penn Davis Mcfarland holds 1.33% in The Mosaic Company (NYSE:MOS) or 199,374 shares. Investment Counsel, a North Carolina-based fund reported 20,065 shares. Next Finance Grp has 593 shares for 0% of their portfolio. Andra Ap reported 123,000 shares. Moody Commercial Bank Tru Division, Texas-based fund reported 13,100 shares. Cutter & Brokerage reported 0.8% in The Mosaic Company (NYSE:MOS). Apg Asset Mngmt Nv invested in 0.02% or 502,953 shares. Commercial Bank stated it has 8,880 shares. Montana-based Da Davidson & has invested 0.01% in The Mosaic Company (NYSE:MOS). Pggm invested in 0% or 44,577 shares. Numeric Invsts Ltd Co accumulated 54,000 shares. Cubist Systematic Strategies Limited Liability Corporation invested in 0.06% or 49,543 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>